Softwr

AI · head to head

LatchBio vs OpenAI API

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Free plan
No
Full reviewWebsite
OpenAI API logo

OpenAI API

Machine Learning

Hosted API for OpenAI's language, embedding, image and audio models, billed per token

From
$0.15/per-million-tokens
Free plan
No
Full reviewWebsite

The short version

  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; OpenAI API cost scales with tokens rather than with seats, so a successful feature's bill grows with its adoption, and an interface that lets users paste long documents has no natural ceiling on spend unless you build one yourself.
  • They diverge on capability: LatchBio covers Agent driven analysis, OpenAI API covers Text and reasoning models.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and OpenAI API actually diverge.

Attributes where LatchBio and OpenAI API differ
AttributeLatchBioOpenAI API
Starting priceOn request$0.15/per-million-tokens
Pricing modelquoteusage-based
PlatformsWebApi
CategoryAIMachine Learning
FoundedUnknown2015

Identical on both: free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in OpenAI API

  • Text and reasoning models
  • Embeddings
  • Speech and audio
  • Image generation
  • Function calling
  • Structured outputs
  • Batch processing
  • Prompt caching

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot OpenAI API
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot OpenAI API
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot OpenAI API
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot OpenAI API

OpenAI API

  • Adding summarisation, drafting or classification to an existing product where building a model would take longer than the product's whole roadmapnot LatchBio
  • Retrieval-augmented question answering over internal documents, using the embedding and generation models togethernot LatchBio
  • Extracting structured records from unstructured text, where schema-constrained output removes most of the parsing problemnot LatchBio
  • Prototyping a language feature quickly to find out whether it is worth the cost of a self-hosted alternative laternot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

OpenAI API

  • Cost scales with tokens rather than with seats, so a successful feature's bill grows with its adoption, and an interface that lets users paste long documents has no natural ceiling on spend unless you build one yourself.
  • Models are deprecated on the vendor's timetable, and a fine-tuned model built on a retired base goes with it, so the tuning work and the data curation behind it must be redone rather than migrated.
  • Behaviour shifts between model versions in ways no test catches unless you wrote one, so prompts tuned over months against a particular snapshot can regress quietly on migration, which makes an evaluation suite a prerequisite rather than an improvement.
  • It cannot run inside your own network, so data residency requirements, air-gapped environments and contracts forbidding third-party processing rule it out regardless of the provider's own security posture.
  • You inherit its availability and its rate limits, so a provider incident is an outage in your product and a traffic spike can be throttled at precisely the moment the feature is proving itself.

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

OpenAI API

$0.15/per-million-tokens
  • GPT-4o mini$0.15/per-million-input-tokens
    • Fast
    • Affordable
  • GPT-4o$5/per-million-input-tokens
    • Multimodal
    • 128K context

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Choose OpenAI API if

  • You need text and reasoning models.
  • You work on Api.
  • You also want embeddings.
OpenAI API review

Questions people ask

Is LatchBio or OpenAI API better?
Neither clearly leads. LatchBio starts at On request and OpenAI API at $0.15/per-million-tokens, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or OpenAI API?
LatchBio starts at On request and OpenAI API at $0.15/per-million-tokens.
Does LatchBio or OpenAI API run on more platforms?
LatchBio runs on Web. OpenAI API runs on Api.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what OpenAI API is typically brought in for.
What can LatchBio do that OpenAI API cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals. OpenAI API covers Text and reasoning models, Embeddings, Speech and audio, Image generation.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

OpenAI API: Is my data used to train the models?

API inputs and outputs are not used for training by default, which differs from the consumer product. Retention periods and enterprise terms change, so read the current data usage policy rather than trusting a summary.

LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

OpenAI API: Can I run these models on my own hardware?

No. The weights are not distributed. If self-hosting is a requirement, you are looking at open-weight models instead, with the operational and quality trade-offs that implies.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

OpenAI API: How is it priced?

Per token, with input and output priced differently and each model priced differently. Batch processing and cached input prefixes reduce it. The practical consequence is that your bill is a function of prompt design, not just of request count.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

OpenAI API: What is the difference from Azure OpenAI Service?

The same model family delivered by Microsoft under an Azure contract, with Azure identity, networking and regional controls, and a different release cadence for new models. Enterprises with an Azure agreement often choose it for procurement and data residency reasons rather than technical ones.

OpenAI API: How do I keep the cost under control?

Cap input length, cache repeated prefixes, route easy requests to smaller models, use the batch path where latency does not matter, and set per-user limits before launch rather than after the first surprising invoice.

Share

Related pages

More on LatchBio

More on OpenAI API

Keep looking

Other head to heads